Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05765812
Title A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Debiopharm International SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | CHE

Facility Status City State Zip Country Details
New York University Langone Medical Center RECRUITING New York New York 10016 United States Details
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics (START) RECRUITING San Antonio Texas 78229 United States Details
Fred Hutchinson Cancer Research Center RECRUITING Seattle Washington 98109 United States Details
Hospital Universitario Vall d'Hebron RECRUITING Barcelona 08035 Spain Details
Clinica Universidad de Navarra (CUN) RECRUITING Madrid 28027 Spain Details
South Texas Accelerated Research Therapeutics (START) RECRUITING Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre RECRUITING Madrid 28041 Spain Details
Clinica Universidad de Navarra (CUN) RECRUITING Pamplona 31008 Spain Details
Hospital Clinico Universitario de Valencia NOT_YET_RECRUITING Valencia 46010 Spain Details
Universitaetsspital Zuerich RECRUITING Zuerich CH-8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field